Novasep and PharmaZell become one group

Novasep, a major CDMO focused on complex small molecules and antibody-drug conjugates (ADCs), and PharmaZell, a leading supplier of highly resilient and specialty APIs, have just closed their merger, following exclusive negotiations initiated in September 2021. This strategic merger creates a technology driven, leading Franco-German CDMO and API manufacturer. Novasep’s…..